Microalgae-Derived Bioactive Compounds for Liver Health: Mechanisms, Therapeutic Potential, and Translational Challenges
Open Access
Abstract
Microalgae are sustainable sources of bioactive compounds with broad hepato-protective potential. This review synthesizes evidence for five major classes—carotenoids such as astaxanthin and fucoxanthin, polysaccharides such as paramylon and fucoidan, phycobiliproteins such as phycocyanin, omega-3 fatty acids, and phenolic extracts—linking their actions to key liver injury mechanisms. Preclinically, these compounds enhance antioxidant defenses, improve mitochondrial function, suppress inflammatory signaling, regulate lipid metabolism, modulate the gut–liver axis, and inhibit hepatic stellate cell activation, thereby attenuating fibrosis. Consistent benefits are observed in models of non-alcoholic and alcoholic fatty liver disease, drug-induced injury, ischemia–reperfusion, and fibrosis, with marked improvements in liver enzymes, oxidative stress, inflammation, steatosis, and collagen deposition. Emerging evidence also highlights their roles in regulating endoplasmic reticulum stress and ferroptosis. Despite their promise, translational challenges include compositional variability, a lack of standardized quality control, limited safety data, and few rigorous human trials. To address these challenges, we propose a framework integrating multi-omics and AI-assisted strain selection with specification-driven quality control and formulation-aware designs—such as lipid carriers for carotenoids or rational combinations like fucoxanthin with low-molecular-weight fucoidan. Future priorities include composition-defined randomized controlled trials in non-alcoholic fatty liver disease, alcoholic liver disease, and drug-induced liver injury; harmonized material specifications; and multi-constituent interventions that synergistically target oxidative, inflammatory, metabolic, and fibrotic pathways.Keywords
Funding Information
- China’s National Key R&D Programs (2021YFA0910800)
- Natural Science Foundation of Shandong Province (ZR2022MC203)
This publication has 99 references indexed in Scilit:
- Ethanol extracts of Isochrysis zhanjiangensis alleviate acute alcoholic liver injury and modulate intestinal bacteria dysbiosis in miceJournal of the Science of Food and Agriculture, 2024
- Endoplasmic reticulum stress in liver diseasesHepatology, 2022
- Paramylon extracted from Euglena gracilis EOD-1 augmented the expression of SIRT1Cytotechnology, 2021
- Potential protective effects of Spirulina platensis on liver, kidney, and brain acrylamide toxicity in ratsEnvironmental Science and Pollution Research, 2021
- Fucoidan protects against subacute diazinon-induced oxidative damage in cardiac, hepatic, and renal tissuesEnvironmental Science and Pollution Research, 2020
- Comparison of Carotenoids for Their Antifibrogenic Effects in Hepatic Stellate CellsLipids, 2019
- Anti‐fibrotic activity of Euglena gracilis and paramylon in a mouse model of non‐alcoholic steatohepatitisFood Science & Nutrition, 2018
- Bio and phyto-chemical effect of Amphora coffeaeformis extract against hepatic injury induced by paracetamol in ratsMolecular Biology Reports, 2018
- Global epidemiology of nonalcoholic fatty liver disease—Meta‐analytic assessment of prevalence, incidence, and outcomesHepatology, 2015
- Biotechnological production of lutein and its applicationsApplied Microbiology and Biotechnology, 2010